Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Vital ChemtechNSE:VITAL +0.96%73 Debt-to-Equity is 0.62 as of Mar. 2026, which is at its 10-year median of 0.62. GuruFocus rates NSE:VITAL with a GF Score™ of 73/100 and a GF Value™ of ₹82.84 (Possible Value Trap). The stock has 10 warning signs investors should review. Among 1,419 Chemicals companies, Vital Chemtech ranks worse than 68.29% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Vital Chemtech's Debt-to-Equity or its related term are showing as below:
NSE:VITAL'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0.31 Med: 0.62 Max: 3.14
Current: 0.62
During the past 7 years, the highest Debt-to-Equity Ratio of Vital Chemtech was 3.14. The lowest was 0.31. And the median was 0.62.
NSE:VITAL's Debt-to-Equity is ranked worse than 68.29% of 1419
companies
in the Chemicals industry
Industry Median: 0.36
vs NSE:VITAL: 0.62
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Vital Chemtech Debt-to-Equity Related Terms
Vital Chemtech Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for Vital Chemtech's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:VITAL vs LIN, SHW, ECL: Debt-to-Equity Comparison
For the Specialty Chemicals subindustry, Vital Chemtech's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vital Chemtech Debt-to-Equity vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Vital Chemtech's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Vital Chemtech's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vital Chemtech (NSE:VITAL) has a Debt-to-Equity of 0.62 as of Mar. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Vital Chemtech and its competitors. This is near median its historical median of 0.62. Over the past decade, Vital Chemtech's Debt-to-Equity has ranged from 0.31 to 3.14. According to the industry distribution chart, Vital Chemtech ranks #969 out of 1419 companies in the Chemicals industry, placing it in the top 68.3%.
Is Vital Chemtech's Debt-to-Equity too high?
Vital Chemtech's current Debt-to-Equity of 0.62 is near median its 10-year median of 0.62. Over the past 10 years, this metric has ranged from a low of 0.31 to a high of 3.14. The Chemicals industry median Debt-to-Equity is 0.36. Vital Chemtech's value of 0.62 is 72.2% above this industry median. Based on the distribution chart, Vital Chemtech ranks #969 out of 1419 companies in the Chemicals industry, which is below the industry midpoint. Overall, Vital Chemtech has a GF Score™ of 73/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Vital Chemtech's Debt-to-Equity compare to LIN and SHW?
According to the Chemicals industry distribution chart, Vital Chemtech ranks #969 out of 1419 companies for Debt-to-Equity. This places Vital Chemtech in the lower half of its industry. The industry median Debt-to-Equity is 0.36. Vital Chemtech's value of 0.62 is 72.2% above this benchmark. Historically, Vital Chemtech's own Debt-to-Equity has ranged from 0.31 to 3.14 over the past decade. While the company's 10-year median is 0.62 vs. the industry median of 0.36, Vital Chemtech has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Chemicals company?
The median Debt-to-Equity among Chemicals companies is 0.36, based on 1,419 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vital Chemtech's current Debt-to-Equity of 0.62 is 72.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Vital Chemtech and its competitors. For the Chemicals industry, the median Debt-to-Equity is 0.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vital Chemtech's current Debt-to-Equity is 0.62, which is near median its own 10-year median of 0.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vital Chemtech stock overvalued right now?
Based on GuruFocus' analysis, Vital Chemtech (NSE:VITAL) is currently considered Possible Value Trap. The stock's GF Value™ is ₹82.84, compared to a current price of ₹55.48 — trading 33% below its estimated fair value. The current Debt-to-Equity is 0.62, which is near median its 10-year median of 0.62 and 72.2% above the Chemicals industry median of 0.36. Vital Chemtech's overall GF Score™ is 73/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Vital Chemtech (NSE:VITAL), the current Debt-to-Equity is 0.62 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vital Chemtech (NSE:VITAL) Overvalued in 2026?
Based on GuruFocus' analysis, Vital Chemtech stock appears to be undervalued.
The current stock price of ₹55.48 is trading 33% below its estimated GF Value™ of ₹82.84.
GuruFocus considers Vital Chemtech to be Possible Value Trap.
Key valuation signals for NSE:VITAL:
Debt-to-Equity: 0.62 (near median its 10-year median of 0.62)
GF Value™: ₹82.84 vs. price of ₹55.48 (33% below fair value)
Industry Position: 72.2% above the Chemicals median (#969 of 1419)
No single metric tells the full story. See the NSE:VITAL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vital Chemtech Ltd is engaged in the business of manufacturing, producing, refining, processing, formulating, mixing, enriching, mining, importing, exporting, acquiring, inventing, buying, selling, exchanging, distributing, and otherwise trading and dealing in all kinds of mixtures, formlations, intermediates, derivatives, compounds, phosphorous based chemicals, fine chemicals, heavy chemicals, valence, inorganic and organic chemicals, source materials, intermediates, ingredients, mixtures, derivatives and compounds. The company's Products include Phosphorus Derivatives, Industrial Chemicals, Specialty Chemicals & Intermediates, Organophosphates, Polymers & Dispersants, and Wellness Products.
73GF Score
Get the complete analysis for NSE:VITAL
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:VITAL has been successfully added to your 
